152 related articles for article (PubMed ID: 7005587)
1. [Therapy of organic psychosyndrome with hydergine and digitalis. A component study using double blind technics].
Pfeiff E; Schlegel HE; Seus R; Dennler HJ; Kugler J
Med Welt; 1980 Sep; 31(39):1403-7. PubMed ID: 7005587
[No Abstract] [Full Text] [Related]
2. [Hydergin therapy of cerebrovascular insufficiency in patients requiring digitalis. Results of a double-blind study (author's transl)].
Dennler HJ; Bachmann H
MMW Munch Med Wochenschr; 1979 Nov; 121(48):1615-8. PubMed ID: 118360
[TBL] [Abstract][Full Text] [Related]
3. Hydergine-thioridazine combination in the treatment of psychopathological states in old age.
Predescu V; Giurezu T; Tudorache D; Nica S; Ionescu R; Nicolschi L; Nitrurad A; Popvici E; Curelaru S
Act Nerv Super (Praha); 1974 Aug; 16(3):237-8. PubMed ID: 4214302
[No Abstract] [Full Text] [Related]
4. [Evaluation of the practical use of mathematical methods and computer technics for the control of treatment with selected digitalis glycosides].
Tytman B
Pol Tyg Lek; 1981 Oct; 36(40):1553-5. PubMed ID: 7335534
[No Abstract] [Full Text] [Related]
5. DH Ergotoxin (Spofa) sublingual tablets in the treatment of cerebrovascular insufficiency in involution: clinical and experimental psychologic study.
Misurec J; Morávek Z; Náhunek K; Cesková E; Sláma B; Svestka J
Act Nerv Super (Praha); 1978 Dec; 20(4):266-7. PubMed ID: 367038
[No Abstract] [Full Text] [Related]
6. Dihydroergocryptine in the management of senile psycho-organic syndrome.
Scarzella L; Bono G; Bergamasco B
Int J Clin Pharmacol Res; 1992; 12(1):37-46. PubMed ID: 1526697
[TBL] [Abstract][Full Text] [Related]
7. [Dihydroergocristine in the treatment of organic brain psychosyndrome. Dose-finding study against placebo].
Milvio C
Arzneimittelforschung; 1992 Nov; 42(11A):1399-402. PubMed ID: 1492861
[TBL] [Abstract][Full Text] [Related]
8. [Effect of piracetam on the brain-organic psychosyndrome in cerebrovascular insufficiency. Results of a double-blind study in 40 cases].
Trabant R; Poljakovic Z; Trabant D
Ther Ggw; 1977 Aug; 116(8):1504-21. PubMed ID: 331549
[No Abstract] [Full Text] [Related]
9. [Time kinetics of effects of digitoxin and beta-acetyl digoxin following oral application in man (author's transl)].
Belz GG; Czermak E; Belz G
Z Kardiol; 1979 Feb; 68(2):77-81. PubMed ID: 371173
[No Abstract] [Full Text] [Related]
10. [Controlled double-blind study of the clinical equivalent of two posologic regimens of Hydergine: 1 x 4,5mg compared to 3 x 1,5mg per day].
Piguet PV; Zoufal Z
Rev Med Suisse Romande; 1981 Feb; 101(2):157-63. PubMed ID: 7015453
[No Abstract] [Full Text] [Related]
11. [Comparison of subjective tolerance of hydergine specific and hydergine in gerontologic therapy].
Ronge J; Dennler HJ
Med Welt; 1982 Oct; 33(42):1485-9. PubMed ID: 6757638
[No Abstract] [Full Text] [Related]
12. [Therapy with cardiac glycosides. Report of clinical experiences with a beta-acetyldigoxin preparation].
Bouzo H; Weise HJ; Samman N; Munding M; Boeck K
Med Welt; 1980; 31(46):1683-5. PubMed ID: 7453558
[No Abstract] [Full Text] [Related]
13. [Treatment of organic brain psychosyndrom in the old age. A double blind study with Hydergin (author's transl)].
Biel ML; Seus R; Struppler A
Med Klin; 1976 Dec; 71(49):2177-84. PubMed ID: 794665
[TBL] [Abstract][Full Text] [Related]
14. Activity of oxiracetam in patients with organic brain syndrome: a neuropsychological study.
Moglia A; Sinforiani E; Zandrini C; Gualtieri S; Corsico R; Arrigo A
Clin Neuropharmacol; 1986; 9 Suppl 3():S73-8. PubMed ID: 3594459
[TBL] [Abstract][Full Text] [Related]
15. [Controlled clinical study on beta-acetyldigoxin].
Marsala F
Clin Ter; 1984 Aug; 110(3):243-9. PubMed ID: 6237862
[No Abstract] [Full Text] [Related]
16. [Controlled clinical study of use of dihydroergocristine in cerebral and periferal vascular disorders].
Calisti G; Biscarini L; Miseo A
Clin Ter; 1977 Nov; 83(4):371-86. PubMed ID: 414875
[No Abstract] [Full Text] [Related]
17. [Therapeutic effectiveness and safety of dihydroergocristine. A study of 9,702 patients].
Mailland F; Zottino G
Fortschr Med; 1986 Mar; 104(11):239-42. PubMed ID: 3084366
[No Abstract] [Full Text] [Related]
18. [Experiences with Card-hydergine in patients with cardiac insufficiency and cerebrovascular disorders in professional practice].
Kohler H
Med Monatsschr; 1976 Nov; 30(11):516-8. PubMed ID: 792670
[No Abstract] [Full Text] [Related]
19. [Comparison of dihydroergotoxine and placebo in the treatment of moderate arterial hypertension in older persons].
Bagatin J; Rumboldt Z; Jurisić M; Vujić D
Med Pregl; 1988; 41(1-2):74-7. PubMed ID: 3054457
[No Abstract] [Full Text] [Related]
20. Hydergine: a review of 26 clinical studies.
McDonald RJ
Pharmakopsychiatr Neuropsychopharmakol; 1979 Nov; 12(6):407-22. PubMed ID: 538085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
